Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

NCT02054637 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acid Reflux Esophagitis
Non-acid Reflux Esophagitis

Interventions

DRUG: Lanreotide

Sponsor

Universitair Ziekenhuis Brussel